genOway Société anonyme (ALGEN.PA)
Creates genetically modified mice and rats for drug research and testing.
2.46-0.02%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-19.1%
The outlook
ALGEN.PA is trading near the middle of its 52-week range with mixed price momentum relative to its moving averages. The stock carries a neutral sentiment score, and analyst coverage appears limited. At a trailing P/E of 24.6, valuation sits at a moderate premium to the broader market.
What’s behind the score
Price trendMixed vs its moving averages
52-week range33% of the way from its 52-week low to high
Market cap
$30.4M
52-wk high
3.20
52-wk low
2.10
50-day avg
2.41
200-day avg
2.48
Trailing P/E
24.6